SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-031433
Filing Date
2024-03-14
Accepted
2024-03-14 16:00:12
Documents
1
Period of Report
2024-03-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6507
  Complete submission text file 0000950170-24-031433.txt   8056
Mailing Address C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR, STE 250 PALO ALTO CA 94304
Business Address
Kumar Neil (Reporting) CIK: 0001742485 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 24749602

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)